DNases, Ligases, And RNA Polymerases Market Summary

The global DNases, ligases, and RNA polymerases market size was estimated at USD 801.9 million in 2023 and is projected to reach USD 1.62 billion by 2030, growing at a CAGR of 10.63% from 2024 to 2030. This strong growth reflects the expanding role of enzyme-based technologies in modern life sciences and biopharmaceutical research. The market is witnessing growth due to the growing academic and industrial interest in mRNA technology, advancements in biotechnology and molecular biology, and increasing demand for gene therapy, all of which rely heavily on these enzymes for research, development, and production processes.

Recently, RNA centers have been established at numerous institutions to promote the therapeutic application of RNA, particularly In Vitro Transcribed mRNA, which is increasingly used in vaccines and novel therapeutics. These initiatives are accelerating research activities and driving demand for high-quality DNases, ligases, and RNA polymerases. The COVID-19 pandemic has had a significant impact on the DNases, ligases, and RNA global market, with a notable positive effect seen in the development of mRNA-based vaccines. The rapid deployment and success of these vaccines highlighted the critical importance of RNA technologies and supported long-term investment in related enzyme markets.

Key Market Trends & Insights

• The North America DNases, ligases, and RNA polymerases market dominated the global industry and accounted for a share of 36.22% in 2023, supported by strong research infrastructure, substantial funding for biotechnology, and the presence of leading pharmaceutical and biotechnology companies.
• The Asia Pacific DNases, ligases, and RNA polymerases market is anticipated to witness the fastest CAGR of 13.61% from 2024 to 2030, driven by increasing research activities, expanding biopharmaceutical manufacturing capabilities, and growing government support for life sciences in countries such as China, India, and South Korea.
• Based on application, the mRNA production segment observed lucrative growth and held the highest revenue share of 75.79% in 2023, reflecting the rapid expansion of mRNA-based therapeutics and vaccines.
• In terms of ligases application, the other applications segment held the largest revenue share of 55.84% in 2023, indicating broad utilization of ligases across diverse molecular biology workflows.
• Based on DNases application, the biopharmaceutical processing segment accounted for the largest revenue share of 78.43% in 2023, due to the extensive use of DNases in downstream processing and purification steps.

Order a free sample PDF of the DNases, Ligases, And RNA Polymerases Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 801.9 Billion
• 2030 Projected Market Size: USD 1.62 Billion
• CAGR (2024-2030): 10.63%
• North America: Largest market in 2023
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

Key players operating in the DNases, ligases, and RNA polymerases market are undertaking various initiatives to strengthen their market presence and increase the reach of their products and services. Strategies, such as expansion activities and partnerships, play a key role in propelling market growth.

Key Players

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Agilent Technologies, Inc.
• Promega Corporation
• New England Biolabs
• RayBiotech, Inc.
• BioVision, Inc.
• ABclonal, Inc.
• QIAGEN N.V.
• Takara Bio, Inc.
• Abnova Corporation
• Calzyme
• ArcticZymes Technologies
• Worthington Biochemical Corporation
• MBL International
• MyBioSource
• BPS Bioscience Inc.
• Sino Biological
• Novus Biologicals

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The DNases, ligases, and RNA polymerases market is experiencing robust growth driven by the rapid expansion of mRNA technologies, gene therapy research, and biopharmaceutical development. Increased academic and industrial investments, along with lessons learned from the COVID-19 pandemic, are strengthening long-term demand for these enzymes. Regional trends highlight North America’s strong market presence and Asia Pacific’s high growth potential. Dominance of mRNA production and biopharmaceutical processing applications underscores the critical role of these enzymes. Overall, continued innovation and research activity are expected to sustain market growth through the forecast period.